|
Bionomics Limited - Company Profile Snapshot
| Company Profile: |
Bionomics Limited |
| Ticker: |
BMICY |
| Exchanges: |
OTC |
| 2009 Sales: |
1,440,400 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
AUSTRALIA |
| Employees: |
|
Business Description
Bionomics Limited. The Company's principal activity is undertaking research and development utilising the Company's proprietary technology platforms with the aim of identifying and developing therapies to treat cancer and conditions of the Central Nervous System (CNS), including anxiety multiple sclerosis and epilepsy. Other activities include commercialising intellectual property assets and identifying strategic alliances and project opportunities capable of increasing shareholder value and of enhancing the its competitive advantage within the biotechnology industry. The Company operates in two geographical areas, namely Australia and France.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
